Most of these patients presented with synchronous bilateral tumors, but three had metachronous bilateral disease (intervals of 4.3 to 7 years), and one (QLH) developed a WT1-based secondary AML (acute myeloid leukemia). This evidence concerns the gene WT1 and acute myeloid leukemia.